Rheumatoid arthritis, etc.
Conditions
Interventions
group PCIA :2ug/kg+ dezocine 20mg+ dolasetron 25mg, diluted to 100mL by adding normal saline, no loading volume was set, background infusion rate was set as 2mL/h, and blous volume was 0.5ml/ time
group PCEA :0.1% ropivacaine, load set at 10mL, background infusion rate of 5mL/h, locking time of 20min, blous dose of 5ml/ time
group CFNBA :0.1% ropivacaine, loading volume 10ml, background infusion rate 5ml/h, locking time 20min, blous volume 5ml/ time
Sponsors
Quanzhou First Hospital Affiliated to Fujian Medical University
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Those who meet the relevant diagnostic criteria for knee joint diseases; 2. Patients with TKA treatment indications; 3. ASA GradeI-II; 4. Approved by the ethics committee of our hospital; 5. Those who voluntarily signed the informed consent; 6. Patients with normal preoperative coagulation function; 7. Patients without lower extremity venous thrombosis before operation; 8. No contraindications of anticoagulant drugs; 9. No intraspinal block contraindicated.
Exclusion criteria
Exclusion criteria: 1. Patients with mental diseases, hearing disorders, language disorders, and confusion; 2. Acute inflammatory skin disease; 3. Poor general condition, unable to tolerate surgery; 4. Withdrawal from treatment, change of surgical method, death or loss of contact during follow-up; 5. Patients with inadequate treatment compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain score;Adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| coagulation indicators;the incidence of deep vein thrombosis in the lower extremities; | — |
Countries
China
Contacts
Public ContactZeng Jingyang
Quanzhou First Hospital Affiliated to Fujian Medical University
Outcome results
None listed